Loading…
Massachusetts doubles cannabis possession limits, marijuana breathalyzer breakthrough, North Carolina panel backs legalization, and more.
By Hightree Team for The Canopy
April 8, 2026 · 3 min read
Your daily digest of the stories shaping the cannabis industry. Here's what happened while you weren't looking.
The Massachusetts House passed a sweeping cannabis reform bill that doubles the amount of marijuana consumers can legally purchase. The legislation, which passed unanimously, is part of a broader deal between Beacon Hill lawmakers to modernize the state's marijuana market. The changes affect customers, dispensaries, and regulators alike, potentially creating one of the most consumer-friendly legal cannabis frameworks in the country. For Hightree shoppers in Massachusetts, this means more flexibility when stocking up at licensed retailers. The bill now heads to the Senate.
Sources: Marijuana Moment, WBUR, Worcester Telegram
A new federally funded study has produced a working marijuana breathalyzer — a 3D-printed roadside device capable of detecting THC in a person's breath. If validated at scale, the technology could transform how law enforcement handles cannabis-impaired driving, one of the most persistent challenges since legalization began sweeping the states. Unlike blood or urine tests, a breath-based approach could provide near-instant results during traffic stops. The research addresses a longstanding gap that has complicated DUI enforcement in legal states for years.
Source: Marijuana Moment
A state-appointed advisory council in North Carolina has formally called on lawmakers to legalize and regulate the adult-use cannabis market. The interim report concluded that "a well-regulated market is a safer market" and recommended allowing adults to purchase cannabis through state-licensed retail outlets. The council cited potential benefits including tax revenue, public health oversight, and reduced arrests — North Carolina has seen over 100,000 marijuana-related arrests since 2018, with 93% for simple possession. However, top Republican lawmakers immediately rejected the recommendations. The final report is due in December 2026.
Source: NORML
The marijuana rescheduling timeline continues to evolve. An in-depth analysis from Morningstar this week breaks down how the "order of operations" — particularly the appointment of Todd Blanche to a key role — could define the path to moving cannabis from Schedule I to Schedule III. The rescheduling process involves multiple federal agencies and political dynamics that make the timeline hard to predict, but industry observers say the appointment signals continued momentum. For vendors and operators, Schedule III would unlock banking access, tax relief under 280E, and a fundamentally different business environment.
Source: Morningstar
In the week's biggest M&A move, Vireo Growth Inc. announced its acquisition of The Hawthorne Gardening Company from Scotts Miracle-Gro. The deal includes 213 million shares priced at $0.60 each and 80 million warrants with a $0.85 strike price, bringing approximately $110 million in combined cash and net working capital to Vireo's balance sheet. The acquisition signals continued consolidation in the cannabis cultivation supply chain and positions Vireo as a stronger vertically integrated player.
Source: New Cannabis Ventures
President Trump's latest budget proposal includes a provision to continue protecting state medical marijuana laws from federal interference — maintaining a policy that has been renewed annually since 2014. Notably, the same budget blocks Washington, D.C. from using federal funds to legalize recreational cannabis sales. The mixed signals reflect the administration's pragmatic approach: don't disrupt the 40+ states with medical programs, but don't actively expand federal cannabis policy either. Browse quality products on Hightree from vendors operating in full compliance with their state programs.
Source: Marijuana Moment
Texas hemp court fight, Missouri's hemp ban, North Carolina opens medical door, Virginia bill in limbo, and Indiana's surprise pivot.
The DEA begins accepting applications from state-licensed medical marijuana businesses, marking the first concrete step in implementing Schedule III rescheduling.
State-by-state rescheduling fallout, Trump urges Congress on hemp, IRS tax guidance coming, and 70% of Americans support legalization.